|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0028587,
umls-concept:C0034656,
umls-concept:C0205179,
umls-concept:C0205420,
umls-concept:C0220756,
umls-concept:C0238301,
umls-concept:C0282461,
umls-concept:C0598988,
umls-concept:C0684249,
umls-concept:C1517927,
umls-concept:C1705294,
umls-concept:C1707455,
umls-concept:C2603343
|
|
pubmed:issue |
25
|
|
pubmed:dateCreated |
2005-9-1
|
|
pubmed:abstractText |
We conducted a phase III study to compare the survival impact of concurrent versus sequential treatment with radiotherapy (RT) and chemotherapy (CT) in unresectable stage III non-small-cell lung cancer (NSCLC).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BozonnatMarie-CécileMC,
pubmed-author:DansinEricE,
pubmed-author:DaurésJean-PierreJP,
pubmed-author:DelhoumeJean-YvesJY,
pubmed-author:FournelPierreP,
pubmed-author:Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de...,
pubmed-author:LénaHervéH,
pubmed-author:Le TreutJacquesJ,
pubmed-author:MornexFrançoiseF,
pubmed-author:PérolMauriceM,
pubmed-author:PascalThomasT,
pubmed-author:RobinetGillesG,
pubmed-author:SilvaniJules-AntoineJA,
pubmed-author:SouquetPierre-JeanPJ,
pubmed-author:VergnenégreAlainA
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5910-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16087956-Adult,
pubmed-meshheading:16087956-Aged,
pubmed-meshheading:16087956-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16087956-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:16087956-Cisplatin,
pubmed-meshheading:16087956-Combined Modality Therapy,
pubmed-meshheading:16087956-Dose Fractionation,
pubmed-meshheading:16087956-Drug Administration Schedule,
pubmed-meshheading:16087956-Female,
pubmed-meshheading:16087956-Humans,
pubmed-meshheading:16087956-Lung Neoplasms,
pubmed-meshheading:16087956-Male,
pubmed-meshheading:16087956-Middle Aged,
pubmed-meshheading:16087956-Survival Analysis,
pubmed-meshheading:16087956-Vinblastine
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study.
|
|
pubmed:affiliation |
University Hospital, Saint-Etienne Cedex 2, France. pierre.fournel@chu-st-etienne.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
